| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-N0391G |
| M.Wt: | 175.19 |
| Formula: | C6H13N3O3 |
| Purity: | >98 % |
| Solubility: |
L-Citrulline GMP is an orally active, blood-brain barrier permeable neutral α-amino acid. L-Citrulline GMP inhibits the mitochondrial translocation of Drp1 and maintains mitochondrial homeostasis via a NO-dependent pathway, thereby reducing excessive ROS production. Consequently, L-Citrulline GMP protects sperm DNA integrity, stabilizes the blood-testis barrier and improves semen quality. L-Citrulline GMP can be used in research related to male infertility, mycobacterial infection (tuberculosis) and radiation combined injury[1][2][3].
In Vitro:L-Citrulline (GMP) (1-2 mM) protects mouse C2C12 myoblasts against 43 °C heat stress-induced mitochondrial dysfunction and cell injury via a nitric oxide-mediated inhibition of DRP1 activation[1].
L-Citrulline GMP maintains normal autophagic flux in primary human airway epithelial cells by mitigating asymmetric dimethylarginine-induced nitrative stress via restored nitric oxide bioavailability[1].
In Vivo:L-Citrulline GMP (1 g/kg; p.o.; once daily; 21 days post-irradiation) significantly accelerates skin wound healing in a mouse model of radiation combined injury, improves bone marrow clonogenicity, and produces a non-significant trend toward increased 30-day survival (40% survival rate)[3].
L-Citrulline GMP (1 g/kg; p.o.; once daily; 21 days post-irradiation), in combination with PEG-G-CSF, significantly increases 30-day survival (42% survival rate) in a mouse model of radiation combined injury, accelerates body weight recovery, improves bone marrow clonogenicity, and enhances intestinal crypt recovery[3].
L-Citrulline GMP (1 g/kg; p.o.; once daily; 21 days post-irradiation) does not significantly improve 30-day survival in mice with total-body irradiation alone, but improves bone marrow clonogenicity and partially reduces irradiation-induced splenomegaly[3].
L-Citrulline GMP (1 g/kg; p.o.; once daily; 21 days post-irradiation), in combination with PEG-G-CSF, does not significantly improve 30-day survival in mice with total-body irradiation alone, but improves bone marrow clonogenicity and fully inhibits irradiation-induced splenomegaly[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.